Bank Of America Corp Sonoma Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 172 shares of SNOA stock, worth $452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172
Previous 44
290.91%
Holding current value
$452
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SNOA
# of Institutions
15Shares Held
434KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il195KShares$513,2620.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$119,1250.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$63,9480.0% of portfolio
-
Xtx Topco LTD London, X019.8KShares$52,1630.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.3KShares$40,3040.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $8.16M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...